4
Changes in Ownership
NOVAVAX INC Filed Acc 0001209191-21-058570
President, R&D sold 693 shares at an average $207.25 ($143,622)
From the SEC's structured data for this filing
Trades in this filing
Glenn Gregory M · President, R&D
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-30 | Sale : show line 1 in the form | −51 | $202.84 | $10,345 | 4,703 | D |
| 2021-09-30 | Sale : show line 2 in the form | −55 | $203.94 | $11,217 | 4,648 | D |
| 2021-09-30 | Sale : show line 3 in the form | −16 | $205.01 | $3,280 | 4,632 | D |
| 2021-09-30 | Sale : show line 4 in the form | −280 | $207.01 | $57,962 | 4,352 | D |
| 2021-09-30 | Sale : show line 5 in the form | −117 | $207.99 | $24,335 | 4,235 | D |
| 2021-09-30 | Sale : show line 6 in the form | −118 | $209.27 | $24,694 | 4,117 | D |
| 2021-09-30 | Sale : show line 7 in the form | −40 | $210.16 | $8,406 | 4,077 | D |
| 2021-09-30 | Sale : show line 8 in the form | −16 | $211.39 | $3,382 | 4,061 | D |
| Open-market sales · 693 sh · avg $207.25 · $143,622 | ||||||
Loading xslF345X03/doc4.xml…